AWH News and Press, Aspira Women's Health Inc. From 11/29/22

AUSTIN, Texas, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, announced the commercial launch of OvaWatch SM , a new non-invasive blood-based test for the ...

Aspira Women's Health Inc. (AWH) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Nicole Sandford - President and Chief Executive Officer Ryan Phan - Chief Scientific Officer and Chief Operating Officer Robert Beechey - Chief Fin...

Aspira Women’s Health press release ( NASDAQ: AWH ): Q3 GAAP EPS of -$0.04. Revenue of $2.1M (+23.5% Y/Y). Q3 product volume up 29% to 5,524 units . Q3 gross profit margin for Ova1Plus was relatively flat at 57%. As of Sept  30, 2022, Aspira had...

Increased year-over-year product revenue by 26% to $2.0 million and year-over-year product volume by 29% to 5,524 units Reconfirmed fourth quarter launch of OvaWatch ovarian cancer risk assessment and announced rebranding of the ovarian cancer product portfolio as OvaSuite ...

AUSTIN, Texas, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that the company will report its financial results for the third quarter ended September 30, 2022 before the market open on ...

AUSTIN, Texas, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that management will present and be available for 1x1 meetings at the MicroCap Rodeo Presents Windy City Roundup 2022 confe...

AUSTIN, Texas, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the formal launch of its co-marketing and distribution collaboration with BioRefe...

RALEIGH, NC / ACCESSWIRE / September 27, 2022 / The 2 nd Annual MicroCap Rodeo Conference is going on the road and will take place at the Swissotel in Chicago on October 12 th - 13th, 2022, where 60+ SmallCap, MicroCap and NanoCap public companies will be presenting to a global investor au...

AUSTIN, Texas, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced publication of a study on the use of its multivariate index assay, MIA2G (OVERA ...

Aspira Women's Health ( NASDAQ: AWH ) priced its stock offering it released late on Monday at $9M, comprising the sale of 12M common shares priced at $0.75 apiece. The provider of diagnostic tests for gynecologic disease told the offering will also include the accompan...